339 related articles for article (PubMed ID: 26707470)
1. Bacteriophage endolysins: applications for food safety.
Schmelcher M; Loessner MJ
Curr Opin Biotechnol; 2016 Feb; 37():76-87. PubMed ID: 26707470
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage endolysins as novel antimicrobials.
Schmelcher M; Donovan DM; Loessner MJ
Future Microbiol; 2012 Oct; 7(10):1147-71. PubMed ID: 23030422
[TBL] [Abstract][Full Text] [Related]
3. The Advantages and Challenges of Using Endolysins in a Clinical Setting.
Murray E; Draper LA; Ross RP; Hill C
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920965
[TBL] [Abstract][Full Text] [Related]
4. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
[TBL] [Abstract][Full Text] [Related]
5. Endolysins as antimicrobials.
Nelson DC; Schmelcher M; Rodriguez-Rubio L; Klumpp J; Pritchard DG; Dong S; Donovan DM
Adv Virus Res; 2012; 83():299-365. PubMed ID: 22748813
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.
Donovan DM
Recent Pat Biotechnol; 2007; 1(2):113-22. PubMed ID: 19075835
[TBL] [Abstract][Full Text] [Related]
7. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.
Gondil VS; Harjai K; Chhibber S
Int J Antimicrob Agents; 2020 Feb; 55(2):105844. PubMed ID: 31715257
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage endolysins as a novel class of antibacterial agents.
Borysowski J; Weber-Dabrowska B; Górski A
Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
[TBL] [Abstract][Full Text] [Related]
9. Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.
Walmagh M; Briers Y; dos Santos SB; Azeredo J; Lavigne R
PLoS One; 2012; 7(5):e36991. PubMed ID: 22615864
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophage-Derived Endolysins Applied as Potent Biocontrol Agents to Enhance Food Safety.
Chang Y
Microorganisms; 2020 May; 8(5):. PubMed ID: 32413991
[TBL] [Abstract][Full Text] [Related]
11. Use of high-affinity cell wall-binding domains of bacteriophage endolysins for immobilization and separation of bacterial cells.
Kretzer JW; Lehmann R; Schmelcher M; Banz M; Kim KP; Korn C; Loessner MJ
Appl Environ Microbiol; 2007 Mar; 73(6):1992-2000. PubMed ID: 17277212
[TBL] [Abstract][Full Text] [Related]
12. Phage Endolysins: Advances in the World of Food Safety.
Nazir A; Xu X; Liu Y; Chen Y
Cells; 2023 Aug; 12(17):. PubMed ID: 37681901
[TBL] [Abstract][Full Text] [Related]
13. Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.
Rodríguez-Rubio L; Gutiérrez D; Donovan DM; Martínez B; Rodríguez A; García P
Crit Rev Biotechnol; 2016; 36(3):542-52. PubMed ID: 25603721
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.
Linden SB; Zhang H; Heselpoth RD; Shen Y; Schmelcher M; Eichenseher F; Nelson DC
Appl Microbiol Biotechnol; 2015 Jan; 99(2):741-52. PubMed ID: 25038926
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage endolysins--current state of research and applications.
Loessner MJ
Curr Opin Microbiol; 2005 Aug; 8(4):480-7. PubMed ID: 15979390
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review of the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety: recent advances, challenges, and future perspective.
Khan FM; Chen JH; Zhang R; Liu B
Front Microbiol; 2023; 14():1259210. PubMed ID: 37869651
[TBL] [Abstract][Full Text] [Related]
17. [Lysis of bacterial cells in the process of bacteriophage release--canonical and newly discovered mechanisms].
Woźnica WM; Bigos J; Łobocka MB
Postepy Hig Med Dosw (Online); 2015 Jan; 69():114-26. PubMed ID: 25614679
[TBL] [Abstract][Full Text] [Related]
18. Impacts of food matrix on bacteriophage and endolysin antimicrobial efficacy and performance.
Shannon R; Radford DR; Balamurugan S
Crit Rev Food Sci Nutr; 2020; 60(10):1631-1640. PubMed ID: 30880427
[TBL] [Abstract][Full Text] [Related]
19. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily.
Love MJ; Coombes D; Ismail S; Billington C; Dobson RCJ
Biochem J; 2022 Jan; 479(2):207-223. PubMed ID: 34935873
[TBL] [Abstract][Full Text] [Related]
20. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.
Schmelcher M; Shen Y; Nelson DC; Eugster MR; Eichenseher F; Hanke DC; Loessner MJ; Dong S; Pritchard DG; Lee JC; Becker SC; Foster-Frey J; Donovan DM
J Antimicrob Chemother; 2015 May; 70(5):1453-65. PubMed ID: 25630640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
